| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6f79749e86afce9444a364ab60ca3584
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7bf3a5c3139e025ed44112e9948da59f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae1b47bae01264cce77d2e966d57567d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C235-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-335
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D237-26 |
| filingDate |
2007-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5096d99a282d789c1682103800c93357
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0cb5b41de958e5283fd8a63cc31c3bd |
| publicationDate |
2008-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2008143706-A2 |
| titleOfInvention |
Daa peripheral benzodiazepine receptor ligand for cancer imaging and treatment |
| abstract |
Peripheral Benzodiazepine Receptor (PBR) is an attractive target for tumor imaging and treatment due to its upregulation in numerous cancer cell types. DAAl 106 is a selective PBR ligand with high binding affinity. Aspects of the present invention are series of functionaJized DAAl 106 analogs, which can be conjugated to a variety of signaling and treatment moieties, and are widely applicable in PBR targeted molecular imaging and drug delivery. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4245376-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016061142-A1 |
| priorityDate |
2006-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |